Thailand HDV Cohort

ConditionHDV
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe HIV Netherlands Australia Thailand Research Collaboration

About this trial

There is very limited data of HDV in Thailand. As both HDV and HIV can accelerate the HBV course and increased the risk of death, particularly, among those with low CD4 cells/count, therefore, HDV burden in this special population is unmet need. Therefore, this study plans to perform a nationwide survey of the prevalence and predictor of HDV among people uses drugs (PWID) with and without HIV, HBV/HIV (MSM vs non MSM), HBV related cirrhosis. Findinds from this study will provide the scientific community to understand how important HDV is among HBV patients, this could be used to develop strategies for HDV screening and treatment

Eligibility criteria

Qualifiers

Male or female, aged 18 years and older

Provide signed and dated informed consent form.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

3,152 Participants
are grouped into 1 trial group

Sponsors and collaborators

The HIV Netherlands Australia Thailand Research Collaboration

Lead sponsor

King Chulalongkorn Memorial Hospital

Collaborator

Thai Red Cross AIDS Research Centre

Collaborator

Siriraj Hospital

Collaborator

Taksin Hospital

Collaborator

Gilead Sciences

Collaborator